COPD Journal of Chronic Obstructive Pulmonary Disease · 2011 · 102 citations · 26 references
MedicinePharmacoeconomicsManaged CarePulmonologyResource Utilization AnalysisAnxiety DisordersChronic DiseaseChronic Disease BurdenChronic Obstructive Pulmonary DiseaseComorbidityComorbidity AssessmentAdministrative Claims DataAdministrative Claims Data AnalysisChronic Obstructive Pulmonary Disease EpidemiologyEconomic Burden Of DiseaseEconomic Burden Of IllnessLogistic RegressionPropensity ScoringPulmonary Exacerbations
BACKGROUND: Anxiety and depression are common co-morbidities that can complicate the course of chronic obstructive pulmonary disease (COPD). The purpose of this study was to evaluate their impact on healthcare utilization and costs in a managed care COPD population. METHODS: Administrative claims data were used to conduct a retrospective cohort study of COPD patients ≥ 40 years of age, including those with co-morbid COPD-Depression (including anxiety). COPD-Depression patients were matched to COPD patients without depression (COPD-Only cohort) using propensity scores. Conditional logistic regression models assessed the 1-year risk of COPD exacerbations (i.e., emergency room [ER] visit/inpatient hospitalization) between cohorts. Differences in annual all-cause and COPD-related utilization/costs, along with 2-year costs, were also compared between the cohorts. RESULTS: There were 3,761 patients per cohort. Patients in the COPD-Depression cohort were 77% more likely to have a COPD-related hospitalization (odds ratio [OR] = 1.77, P < 0.001), 48% more likely to have an ER visit (OR = 1.48, P < 0.001), and 60% more likely to have hospitalization/ER visit (OR = 1.60, P < 0.001) compared to the COPD-Only cohort. Average annual all-cause medical cost per patient was $23,759 for COPD-Depression vs $17,765 for COPD-Only (P < 0.001) and total (medical plus pharmacy) cost was $28,961 vs $22,512 (P < 0.001), respectively; corresponding average annual COPD-related medical cost was $2,040 vs $1,392 (P < 0.001) and total cost was $3,185 vs $2,680 (P < 0.001). Similar trends were observed over the 2-year period. CONCLUSIONS: In the COPD population, patients with depression/anxiety have significantly higher risk of COPD exacerbations and annual all-cause and COPD-related costs than patients without these co-morbidities. These findings may have therapeutic implications and seem worthy of further exploration.
26
Chronic Obstructive Pulmonary Disease Surveillance—United States, 1971–2000
David M. Mannino, David M. Homa, Lara J. Akinbami et al. · Respiratory Care · 2002 · 1.3K citations · Full text
Ron Z. Goetzel, Kevin Hawkins, Ronald J. Ozminkowski et al. · Journal of Occupational and Environmental Medicine · 2003 · 697 citations